Free Trial

GSK (GSK) News Today

GSK logo
$39.68 +0.24 (+0.61%)
Closing price 08/29/2025 03:59 PM Eastern
Extended Trading
$39.60 -0.07 (-0.19%)
As of 08/29/2025 07:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Why Is GSK Up Today?

GSK PLC Sponsored ADR (NYSE:GSK) shares are trading higher today, supported by a mix of product approvals, robust profitability and shareholder returns, while legal and investor actions add some caution.

  • Positive Sentiment: UK regulators approved Gepotidacin (Blujepa), GSK’s new oral antibiotic for female urinary tract infections in patients aged 12 and older, expanding GSK’s infectious‐disease franchise. Article Link
  • Positive Sentiment: GSK Pharma reported a 12% increase in profit despite flat revenue, driven by improved operational efficiency and cost controls. Article Link
  • Positive Sentiment: The board declared a quarterly dividend of $0.4206 per ADR, lifting the annualized yield to 4.2%, which should appeal to income‐focused investors.
  • Neutral Sentiment: Shares slid on Thursday, underperforming the broader market amid mixed sector sentiment and ahead of upcoming earnings. Article Link
  • Neutral Sentiment: A local funding bid by GSK’s legacy arm for Ulverston sports projects was unsuccessful, a reputational but non‐financial setback. Article Link
  • Negative Sentiment: Pomerantz LLP launched a class‐action investigation into potential investor claims against GSK, highlighting litigation risk. Article Link
  • Negative Sentiment: An Arizona lawsuit over a discontinued GSK inhaler has been moved to state court, extending legal exposure. Article Link
Posted 1+ days agoAI Generated. May Contain Errors.

GSK Latest News

GSK slides Thursday, underperforms market
UK clears GSK’s new oral antibiotic for UTIs
GSK Pharma re-enters oncology market
What is Zacks Research's Forecast for GSK Q3 Earnings?
Analysts Set Expectations for GSK's Q3 Earnings (NYSE:GSK)
GSK (NYSE:GSK) Stock Acquired Rep. Lisa C. McClain
GSK rises Monday, outperforms market
Get GSK News Delivered to You Automatically

Sign up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

GSK Media Mentions By Week

GSK Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

GSK
News Sentiment

0.51

1.05

Average
Medical
News Sentiment

GSK News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

GSK Articles
This Week

29

22

GSK Articles
Average Week

Get the Latest News and Ratings for GSK and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for GSK and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


This page (NYSE:GSK) was last updated on 8/30/2025 by MarketBeat.com Staff
From Our Partners